Lateral flow test approval process must be reformed, industry leaders say telegraph.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from telegraph.co.uk Daily Mail and Mail on Sunday newspapers.
His site, which includes a distillery, shop, grounds and independently-run restaurant will all be open to the public from May 17 and as such the impact of a test rollout would be diluted, he said. It s an extra precaution which I think we would make use of - if someone was going out to meetings or had been off for a week, for example. But you can test one member of staff as many times a week as you like, if you ve got customers queuing up at the door it doesn t give you as much as a safety net as it would an office where it s the same 100 people going in and out, he said.
Iceni Diagnostics
Iceni Diagnostics developed a point-of-care test that is capable of detecting coronavirus within 15 minutes from a non-invasive sample. The test has the potential to transform disease management of the pandemic as it can be performed in any field-based situation by non-skilled operators.
Chairman Dr Berwyn Clarke said: “We are genuinely delighted and honoured to win this award alongside the other exceptional companies who were finalists in this category. We would like to thank everyone who voted for us, the judges who made the process hugely enjoyable and, most importantly, all the staff and service providers who have helped the company to progress to where it is today.
Rob Field of Iceni Diagnostics, Norwich.
- Credit: Si Barber
The Norwich-based producer of a rapid result coronavirus test has secured £2m in investment to continue its work.
Iceni Diagnostics, which is producing a test which can determine if somebody has Covid-19 within 15 minutes, has received commitments from 35 different investors, which will pump £2m into its coffers in 2021.
The investment means the company, which is based at the Norwich Research Park, will be able to play a central role in the fight against Covid-19 on both sides of the Atlantic.
And the boost comes as it awaits imminent results from its latest trials.